Clinical Study on Guben Kechuan Granules Promoting Disease Recovery by Regulating Immune-Inflammatory Dysregulation in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease During the Peri-Discharge Period
Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine
Traditional Chinese Medicine Hospital of Changji Hui Autonomous Prefecture, Xinjiang
Jinan Hospital of Integrated Traditional Chinese and Western Medicine
Age
40–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Meet the diagnostic criteria for Chronic Obstructive Pulmonary Disease (COPD), with lung function classified as Grade II-IV (Groups B and E).
Be in the peri-discharge period of Acute Exacerbation of COPD (AECOPD).
Conform to the Traditional Chinese Medicine (TCM) syndrome of spleen deficiency with excessive phlegm and insecure kidney qi.
Aged 40-75 years, regardless of gender.
Be an inpatient.
Have no prior use of Guben Kechuan Granules.
Be willing to participate in this study and sign the informed consent form.
You may not be if
Have airflow limitation caused by other respiratory diseases such as bronchial asthma, bronchiectasis, pulmonary tuberculosis, and lung cancer.
Have severe concurrent diseases of the heart, brain, liver, kidney, etc., which render the patient unable to cooperate with exercise.
Have an impaired immune system or be receiving long-term ·immunosuppressive therapy.
Be currently participating in another interventional clinical trial of drugs or medical devices.
Clareo Health | Clinical Study on Guben Kechuan Granules Promoting Disease Recovery by Regulating Immune-Inflammatory Dysregulation in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease During the Peri-Discharge Period
